WO1999017815A1 - Dure-mere artificielle et procede de fabrication de dure-mere - Google Patents
Dure-mere artificielle et procede de fabrication de dure-mere Download PDFInfo
- Publication number
- WO1999017815A1 WO1999017815A1 PCT/JP1998/004488 JP9804488W WO9917815A1 WO 1999017815 A1 WO1999017815 A1 WO 1999017815A1 JP 9804488 W JP9804488 W JP 9804488W WO 9917815 A1 WO9917815 A1 WO 9917815A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- artificial
- dura
- sheet
- artificial dura
- copolymer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
Definitions
- the present invention relates to an artificial dura used for filling a dura defect in the field of neurosurgery and a method for producing the same.
- the dura intervening between the skull and the brain and covering the spinal cord primarily serves to protect the brain and spinal cord and prevent leakage of cerebrospinal fluid, but is deficient in surgery in the field of neurosurgery. It has to be compensated for by contracture, etc. Conventionally, freeze-dried human dura has been used for this.
- an artificial hardening membrane composed of a sheet of a biodegradable absorbent polymer, for example, a copolymer of lactic acid and force prolactone
- an artificial dura or the like is proposed in which a biodegradable and absorptive high molecule different from the material of the sheet is interposed as a reinforcing material in the middle of the sheet, and this is integrated.
- An object of the present invention is to provide an artificial dura with improved quality, such as liquid leakage and suture strength, and a method for producing the same, with respect to the improvement of the artificial dura proposed in the above publication.
- FIG. 1 is a photograph showing a state in which a suture is passed through the artificial dura mater according to the present invention in Example 1.
- FIG. 2 is a photograph showing a state in which a suture is passed through the artificial dura mater of the present invention in Example 2.
- FIG. 3 is a photograph showing a state in which a suture thread has been passed through e-PTFE (Goretex (registered trademark)) manufactured by Goa.
- e-PTFE Goretex (registered trademark)
- FIG. 4 is a photograph showing a state in which a suture has been penetrated through freeze-dried cadaver dura (Tuptoplastura (registered trademark)) manufactured by Tokibo.
- FIG. 5 is a photograph showing a state in which a suture is penetrated through the artificial dura of the present invention in Example 1 and then the suture is extracted.
- FIG. 6 is a photograph showing a state in which a suture is penetrated through the artificial dura of the present invention in Example 2 and then the suture is extracted.
- FIG. 7 is a photograph showing a state in which a suture is passed through e-PTFE (Goretex (registered trademark)) manufactured by Goa and then the suture is removed.
- e-PTFE Goretex (registered trademark)
- FIG. 8 is a photograph showing a state in which a suture is passed through a freeze-dried cadaver dura (Tuptoplastura (registered trademark)) manufactured by Tokibo Co., and then the suture is removed.
- cadaver dura Teuptoplastura (registered trademark)
- the present invention provides an artificial hardening film which is made of at least a sheet of a biodegradable and absorbable synthetic polymer and has a storage elastic modulus at room temperature of 1 ⁇ 10 7 to 5 ⁇ 10 8 (Pa).
- the present invention provides an artificial hardening film characterized by dissolving a lactide s-force prolactone copolymer (copolymerization molar ratio: 40-60 to 40/40) in a solvent, filtering, casting and air-drying. It is intended to provide a manufacturing method.
- the present invention provides (1) dissolving a lactide- ⁇ -force prolactone copolymer (copolymerization ratio of 4060 to 60/40) in a solvent, filtering, and then casting.
- the present invention provides a method for treating a dura defect comprising suturing the remaining dura and the artificial dura of the present invention to cover the defect.
- examples of the biodegradable and absorbable synthetic polymer include aliphatic polyesters (polyglycolic acid, polylactic acid, polycaprolactone, polyvalerolactone and copolymers thereof) and polyester ethers (poly-1). , 4-dioxanone-2-one, poly-1,5-dioxepan-2-one, ethylene glycol—the aliphatic polyester copolymer, propylene glycol / polyester the aliphatic polyester copolymer), and the fat Copolymers of aliphatic polyesters and polyester ethers are preferred. Lactic acid (L-form, D-form, DL-form) and force-prolactone copolymer are more preferable, and L-lactic acid and ⁇ -force-prolactone are more preferable. Is a copolymer of
- Lactic acid nocaprolactone copolymer is preferred because mechanical properties and decomposition rate can be easily controlled, and the copolymerization molar ratio of both is preferably 4060 to 60/40. If the ratio of lactic acid exceeds 60% in such a copolymer molar ratio, the copolymer becomes hard. Similarly, even if the ratio of caprolactone exceeds 60%, the copolymer becomes too hard and may damage the brain surface, so it is not suitable for this use.
- the tensile strength at break is 4 to 2 OMPa
- the Young's modulus at 10% elongation is 9 to 40 MPa
- the bending hysteresis is 0.05 to: L gf cm / cm
- the bending hardness is 0.1 to 2 gfcm. 2 / cm is preferred.
- the tensile strength at break is 4 MPa or more, preferably 4 to 2 OMPa.
- the Young's modulus at 10% elongation is smaller than 9 MPa
- the bending hysteresis is smaller than 0.05 gf cm / cm
- the bending hardness is 0.1 lgfcm 2 / cm. Smaller ones are difficult to produce, and those having a Young's modulus at 10% elongation of more than 4 OMPa, one having a bending hysteresis of more than lgfcm / cm, and one having a bending hardness of more than 2 gfcm 2 / cm. Things become harder and the surface of the brain becomes more vulnerable.
- the elongation at break is 30 ⁇ : L 50%, and the suture strength is 1.5 ⁇ 5.0 Kgf / mm. preferable. If the elongation at break is less than 30%, there is no elongation at the time of suturing with tension, and it will be broken.If it is more than 150%, pressure will be applied due to excessive elongation. Liquid leaks when Furthermore, when suturing with tension, there is a problem that it is difficult to sew because it is too stretched.
- the suture strength is 1.5 Kgf / mm or more, and preferably 1.5 to 5.0 Kgf / thigh.
- the reinforcing material when the reinforcing material is a polyglycolic acid nonwoven fabric, it is hydrolyzed earlier than the sheet portion after a short period of embedding, so that it becomes a film-like space with an open mesh, and the strength is low. Degrades and decomposes faster than film alone. In addition, when viewed from a nonwoven fabric, the decomposition is slower because it is covered with a sheet than polyglycolic acid alone. This is necessary to maintain suture strength. In addition, by making the decomposition rate of the entire product faster than that of the sheet alone, it means that it is absorbed immediately after the period required as a substitute dura, reducing the burden on the body.
- the amount of reinforcing material it is possible to change the decomposition rate within a certain range.
- the reinforcing material is a copolymer of lactic acid and dextran prolactone, the sheet part and the decomposition period are almost constant, so that it can be used when long-term embedding is required.
- the product when the elongation of the reinforcing material is set lower than that of the sheet, the product changes according to the elongation of the reinforcing material.
- a synthetic sheet with the softness required for artificial dura is too stretchy, too stretched under tension, or deformed by applying force during suturing without opening a hole.
- the elongation can be suppressed by the reinforcing material. This means easy handling during suturing during actual surgery.
- the artificial dura composited with the knitted or woven fabric when used as the reinforcing material, also has elasticity, and is suitably used for prosthesis for a movable portion.
- the storage elastic modulus at room temperature is larger than 5 ⁇ 10 8
- 1 X 10 7 smaller than soft or too much for difficult to handle. If the ratio between the loss elastic modulus and the storage elastic modulus exceeds 0.2, plastic deformation is remarkable, and a needle hole is punctured at the time of suturing, and cerebrospinal fluid may leak from the hole, which is not preferable.
- the artificial dura mater of the present invention is obtained by penetrating a suture with a needle, holding the suture in the penetrating part, and then leaking water from the penetrating part (JISL 1092 (water resistance test) method A (low water pressure method). )) Is 10% or less (initial pressure 50 mmHg, 60 minutes), preferably 5% or less, more preferably 3% or less, further preferably 2% or less, most preferably 1.5% or less, particularly 1. 1% or less.
- the thickness of the artificial dura of the present invention is 50 to 800 m, preferably 100 to 300 m.
- the thickness of the sheets on both surfaces is 25 to 400 rn, preferably 50 to 150 m
- the thickness of the reinforcing material is 20 to 500 jm, preferably 50 to 200 m. is there.
- the weight average molecular weight of the lactic acid-force prolactone copolymer is about 100,000 to 500,000, preferably about 150,000 to 300,000.
- the intrinsic viscosity of polyglycolic acid is about 0.8 to 1.8, preferably about 1.0 to 1.4.
- the sheet of the biodegradable and absorbable synthetic polymer constituting the artificial dura mater of the present invention is preferably a smooth sheet having no surface irregularities.
- a sheet having such a smooth surface can be obtained by dissolving in a solvent, filtering, casting, and air-drying.
- the sheet made of the lactic acid monoprolactone copolymer produced by the casting method of the present invention is a smooth sheet having no irregularities on the surface, and therefore, as shown in FIG. 1, there is no void around the suture. No liquid leakage occurs.
- an artificial dura and a method for producing an artificial dura with further improved quality aspects such as liquid leakage and suture strength.
- the JISL 1092 A method is a water resistance test by the low water pressure method. (Example 1)
- L-lactide ⁇ -force prolactone copolymer (molar ratio: 50-50, weight average molecular weight by GPC: 220,000, hereinafter referred to as P (L-LA / CL) (molar ratio: 50-50)) was prepared by a conventional method. did.
- the polyglycolic acid obtained in (2) was spun so as to have a density of about 20 denier, and then drawn.
- the drawn yarn was knitted in a tube and punched with a $ 21 dollar to form a nonwoven fabric.
- the 2 obtained film (sheet) 140 On both sides of the obtained reinforcing material (nonwoven fabric) at 3, the 2 obtained film (sheet) 140:, 5 OKg / cm 2 artificial dura mater of the integrally molded to a three-layer structure by a vacuum press at (film 200 mm).
- Example 1 (1) The two sheets obtained in Example 1 (1) were stacked at 140: and 50 Kg / cm 2 , and were integrally molded by a vacuum press to form a P (L-LA / CL) film (film thickness 200 m). Obtained.
- Example 3 obtained in the reinforcing material of Example 1 (nonwoven fabric), sandwiched from both sides with a sheet (film) 2 sheets obtained in 2, it 120 ⁇ , and vacuum press at 10 Kg / cm 2, the nonwoven fabric sheet A three-layer film (250 / xm in thickness) was obtained by integrating them so that they would not be embedded in the sheet.
- Example 1 The artificial dura mater of the present invention obtained in Example 1 and Example 2, e-PTFE (Gotex (registered trademark)) manufactured by Goa, and freeze-dried cadaver dura manufactured by Toukipo Co., Ltd. ))
- e-PTFE Gotex (registered trademark)
- JISL 1092 water resistance Test
- the test was performed according to the water leakage method of Method A (low water pressure method). That is, each test piece was clamped with the thread passing through each test piece, the water level of the level device was raised to 70 cm, and the water level after a certain period of time was measured.
- the results are shown in Table 1. This test result is not expressed in unit area because water leaked only from the penetrating part (needle hole).
- the measurement temperature was 37 ⁇ :.
- Each of the artificial hardening films of the present invention obtained in Examples 1 to 3 was cut into test pieces of 1 ⁇ 8 cm, and a tensile test was performed at a distance between chucks of 5 cm and a tensile speed of 100 t / min.
- Example 1 Each of the artificial dura maters of the present invention obtained in Example 1 and Example 2 was cut into a 1 ⁇ 4 cm test piece, and a portion 3 mm from the end was fitted with a nylon monofilament No. 3-0. After passing the suture, a tensile test was performed at a chuck-to-chuck distance of 10 cm and a bow I tension speed of 10 Omm / min to measure the suture strength.
- Example 1 The artificial dura mater of the present invention obtained in Example 1 and Example 2 was cut into 1 ⁇ 8 cm test pieces, and the bending hardness and bending hysteresis were measured using a pure bending tester (KES-FB2). It was measured.
- Table 2 shows the test results of (1) to (3).
- Example 3 The tensile strength at break is higher in Example 1 (reinforced with nonwoven fabric) than in Example 2, but the elongation is 1 to 3 which is almost a value close to that of a biological dura. .
- Example 3 the absolute value of the tensile strength at break was almost the same as that in Example 2, and the elongation was about twice that in Example 1 despite the use of nonwoven fabric.
- the elongation can be arbitrarily adjusted by embedding a nonwoven fabric of a certain elongation or by changing the degree of integration.
- Example 1 it can be seen that various characteristic values are better in Example 1 than in Example 2.
- the present invention has a softness that is satisfactory as an artificial hardening film near the temperature used as a medical device, and the loss elastic modulus is lower than the storage elastic modulus. It can be seen that deformation is difficult. Actually, the results of the water leakage test and the photographs of the needle holes (Figs. 1 and 2) showed that both Examples 1 and 2 showed that plastic deformation was difficult.
- Example 1 The product of the present invention obtained in Example 1, Example 2, and Example 3 was cut into a 1 ⁇ 8 cm strip to obtain a test piece.
- the specimen was immersed in 37 ⁇ saline. After a certain period, the sample was taken out, and a tensile test was performed using a tensile tester at a distance between chucks of 5 cm and a tensile speed of 10 Omm / min to measure a change in strength.
- Table 4 shows the test results.
- Example 1 g of the product of the present invention obtained in Example 1, Example 2, and Example 3 was weighed to obtain a test piece.
- the specimen was immersed in saline at 37. After a certain period, it was taken out, dried in a vacuum dryer at room temperature for 24 hours, and the change was measured by measuring the weight. Table 5 shows the test results.
- the implantable sample decomposed the fastest in both the tensile test and the residual weight test.
- the same operation as in the first embodiment is performed at an early stage, but is performed at a later stage. It behaved as in Example 2.
- the above suggests that the initial properties and decomposition period can be controlled by the presence or absence of the reinforcing material and the shape of the integration.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002305410A CA2305410C (en) | 1997-10-06 | 1998-10-05 | Artificial dura mater and process for producing dura mater |
AU92837/98A AU9283798A (en) | 1997-10-06 | 1998-10-05 | Artificial dura mater and process for producing dura mater |
EP98945613A EP1025870B1 (en) | 1997-10-06 | 1998-10-05 | Process for producing artificial dura mater |
US09/529,073 US6514291B1 (en) | 1997-10-06 | 1998-10-05 | Artificial dura mater and process for producing dura mater |
DE69833496T DE69833496T8 (de) | 1997-10-06 | 1998-10-05 | Verfahren zur Herstellung künstlicher Dura Mater |
JP2000514683A JP3559902B2 (ja) | 1997-10-06 | 1998-10-05 | 人工硬膜及び人工硬膜の製造方法 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9/290347 | 1997-10-06 | ||
JP29034797 | 1997-10-06 |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/529,073 A-371-Of-International US6514291B1 (en) | 1997-10-06 | 1998-10-05 | Artificial dura mater and process for producing dura mater |
US09529073 A-371-Of-International | 1998-10-05 | ||
US10/310,521 Continuation US6846330B2 (en) | 1997-10-06 | 2002-12-05 | Artificial dura mater and process for producing dura mater |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999017815A1 true WO1999017815A1 (fr) | 1999-04-15 |
Family
ID=17754882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1998/004488 WO1999017815A1 (fr) | 1997-10-06 | 1998-10-05 | Dure-mere artificielle et procede de fabrication de dure-mere |
Country Status (9)
Country | Link |
---|---|
US (2) | US6514291B1 (ja) |
EP (1) | EP1025870B1 (ja) |
JP (1) | JP3559902B2 (ja) |
KR (1) | KR100419563B1 (ja) |
CN (1) | CN1187100C (ja) |
AU (1) | AU9283798A (ja) |
CA (1) | CA2305410C (ja) |
DE (1) | DE69833496T8 (ja) |
WO (1) | WO1999017815A1 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005102404A1 (ja) * | 2004-04-19 | 2005-11-03 | Kawasumi Laboratories, Inc. | 人工硬膜及びその製造方法 |
WO2009069558A1 (ja) * | 2007-11-29 | 2009-06-04 | Gunze Limited | 医療用インプラント用ラクチド/ε-カプロラクトン共重合体、医療用インプラント用ラクチド/ε-カプロラクトン共重合体の製造方法、医療用インプラント及び人工硬膜 |
JP2009131358A (ja) * | 2007-11-29 | 2009-06-18 | Gunze Ltd | 人工硬膜 |
JP5313142B2 (ja) * | 2007-08-09 | 2013-10-09 | グンゼ株式会社 | 生体器官用補綴材 |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001309969A (ja) * | 2000-04-28 | 2001-11-06 | Gunze Ltd | 人工硬膜 |
US6746661B2 (en) * | 2000-11-16 | 2004-06-08 | Microspherix Llc | Brachytherapy seed |
JP2006500115A (ja) | 2000-11-16 | 2006-01-05 | マイクロスフエリツクス・エル・エル・シー | 密封小線源治療用の可撓性および/または弾性シードまたはストランド |
US7641958B2 (en) * | 2002-04-25 | 2010-01-05 | Gore Enterprise Holdings, Inc. | Membrane for use in sutured or sutureless surgical procedures |
US7736293B2 (en) * | 2005-07-22 | 2010-06-15 | Biocompatibles Uk Limited | Implants for use in brachytherapy and other radiation therapy that resist migration and rotation |
US8187159B2 (en) | 2005-07-22 | 2012-05-29 | Biocompatibles, UK | Therapeutic member including a rail used in brachytherapy and other radiation therapy |
US7902303B2 (en) | 2005-12-30 | 2011-03-08 | Industrial Technology Research Institute | Aliphatic polyester polymer compositions and preparation method thereof |
JP5334360B2 (ja) * | 2006-06-28 | 2013-11-06 | グンゼ株式会社 | 金属触媒の含有量が少ない生体内分解吸収性高分子の製法 |
ATE508155T1 (de) * | 2007-06-23 | 2011-05-15 | Ind Tech Res Inst | Aliphatische polyester-polymer-zusammensetzungen und herstellungsverfahren dafür |
US8852621B2 (en) * | 2008-10-07 | 2014-10-07 | Nanonerve, Inc. | Multilayer fibrous polymer scaffolds, methods of production and methods of use |
KR20110133599A (ko) | 2009-03-10 | 2011-12-13 | 메드프린 리제너레이티브 메디컬 테크놀러지스 컴퍼니 리미티드 | 인공 경질막 및 인공 경질막의 제조방법 |
KR101526002B1 (ko) * | 2012-07-12 | 2015-06-04 | 제일모직주식회사 | 복합시트, 그 제조방법 및 이를 포함하는 플렉시블 기판 |
ES2897898T3 (es) | 2013-12-17 | 2022-03-03 | Nurami Medical Ltd | Una matriz multicapa sustituta de tejidos y usos de la misma |
DE102014202578A1 (de) | 2014-02-12 | 2015-08-13 | Aesculap Ag | Medizinisches Produkt und Verfahren zu seiner Herstellung |
CN104399128A (zh) * | 2014-11-10 | 2015-03-11 | 苏州维泰生物技术有限公司 | 一种复合人工硬脑膜及其制备方法 |
NL2016524B1 (en) * | 2016-03-31 | 2017-10-17 | Polyganics Ip B V | Tissue-adhesive material |
WO2018067811A1 (en) * | 2016-10-05 | 2018-04-12 | Children's Hospital Medical Center, Center For Technology Commercialization | Shape memory patch for tissue repair |
KR102612077B1 (ko) | 2021-09-07 | 2023-12-07 | 가톨릭대학교 산학협력단 | 뇌 보호 패드 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0880344A (ja) * | 1994-09-12 | 1996-03-26 | Gunze Ltd | 人工硬膜 |
JPH09140785A (ja) * | 1995-11-22 | 1997-06-03 | Jms Co Ltd | 生体分解性医療用フィルムおよびその製造方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4045418A (en) * | 1975-01-28 | 1977-08-30 | Gulf Oil Corporation | Copolymers of D,L-lactide and epsilon caprolactone |
US4596839A (en) | 1981-09-16 | 1986-06-24 | Peters William E | Elastomer PTFE composition |
FI83729C (fi) | 1987-11-26 | 1991-08-26 | Biocon Oy | Kirurgisk implantat. |
US5250584A (en) * | 1988-08-31 | 1993-10-05 | G-C Dental Industrial Corp. | Periodontium-regenerative materials |
EP0645400B1 (en) | 1993-09-27 | 1998-04-01 | Mitsubishi Chemical Corporation | Ethylene polymer and fuel tank comprising the same |
JP3395332B2 (ja) | 1994-03-16 | 2003-04-14 | 三菱電機株式会社 | 車両用交流発電機の固定子およびその製造方法 |
CA2173508A1 (en) * | 1995-03-31 | 1996-10-01 | Tooru Yui | Medical device and method for producing the same |
KR19990010319A (ko) * | 1997-07-16 | 1999-02-18 | 김윤 | 강력 유지율 및 생분해성이 조절가능한 2성분계 수술용 봉합사 |
US6410649B1 (en) | 1998-03-23 | 2002-06-25 | Denki Kagaku Kogyo Kabushiki Kaisha | Resin composition |
JP3523082B2 (ja) | 1998-09-04 | 2004-04-26 | 株式会社巴川製紙所 | 樹脂組成物及びそれを用いた接着方法 |
-
1998
- 1998-10-05 JP JP2000514683A patent/JP3559902B2/ja not_active Expired - Lifetime
- 1998-10-05 EP EP98945613A patent/EP1025870B1/en not_active Expired - Lifetime
- 1998-10-05 CA CA002305410A patent/CA2305410C/en not_active Expired - Fee Related
- 1998-10-05 KR KR10-2000-7003695A patent/KR100419563B1/ko not_active IP Right Cessation
- 1998-10-05 US US09/529,073 patent/US6514291B1/en not_active Expired - Fee Related
- 1998-10-05 DE DE69833496T patent/DE69833496T8/de active Active
- 1998-10-05 AU AU92837/98A patent/AU9283798A/en not_active Abandoned
- 1998-10-05 CN CNB988099195A patent/CN1187100C/zh not_active Expired - Lifetime
- 1998-10-05 WO PCT/JP1998/004488 patent/WO1999017815A1/ja active IP Right Grant
-
2002
- 2002-12-05 US US10/310,521 patent/US6846330B2/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0880344A (ja) * | 1994-09-12 | 1996-03-26 | Gunze Ltd | 人工硬膜 |
JPH09140785A (ja) * | 1995-11-22 | 1997-06-03 | Jms Co Ltd | 生体分解性医療用フィルムおよびその製造方法 |
Non-Patent Citations (1)
Title |
---|
See also references of EP1025870A4 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005102404A1 (ja) * | 2004-04-19 | 2005-11-03 | Kawasumi Laboratories, Inc. | 人工硬膜及びその製造方法 |
JPWO2005102404A1 (ja) * | 2004-04-19 | 2008-03-13 | 川澄化学工業株式会社 | 人工硬膜及びその製造方法 |
US7736393B2 (en) | 2004-04-19 | 2010-06-15 | Kawasumi Laboratories, Inc. | Artificial dura mater and process for producing the same |
JP4772669B2 (ja) * | 2004-04-19 | 2011-09-14 | 川澄化学工業株式会社 | 人工硬膜及びその製造方法 |
JP5313142B2 (ja) * | 2007-08-09 | 2013-10-09 | グンゼ株式会社 | 生体器官用補綴材 |
WO2009069558A1 (ja) * | 2007-11-29 | 2009-06-04 | Gunze Limited | 医療用インプラント用ラクチド/ε-カプロラクトン共重合体、医療用インプラント用ラクチド/ε-カプロラクトン共重合体の製造方法、医療用インプラント及び人工硬膜 |
JP2009131358A (ja) * | 2007-11-29 | 2009-06-18 | Gunze Ltd | 人工硬膜 |
Also Published As
Publication number | Publication date |
---|---|
KR20010015700A (ko) | 2001-02-26 |
EP1025870B1 (en) | 2006-02-15 |
US6846330B2 (en) | 2005-01-25 |
US6514291B1 (en) | 2003-02-04 |
EP1025870A1 (en) | 2000-08-09 |
KR100419563B1 (ko) | 2004-02-19 |
DE69833496T8 (de) | 2007-03-29 |
DE69833496D1 (de) | 2006-04-20 |
US20030132546A1 (en) | 2003-07-17 |
CN1187100C (zh) | 2005-02-02 |
CN1274292A (zh) | 2000-11-22 |
CA2305410C (en) | 2007-08-21 |
CA2305410A1 (en) | 1999-04-15 |
EP1025870A4 (en) | 2002-07-24 |
AU9283798A (en) | 1999-04-27 |
DE69833496T2 (de) | 2006-11-02 |
JP3559902B2 (ja) | 2004-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999017815A1 (fr) | Dure-mere artificielle et procede de fabrication de dure-mere | |
JP2987064B2 (ja) | 人工硬膜 | |
JP4251665B2 (ja) | コラーゲン材及びその製法 | |
KR100803798B1 (ko) | 의료용 필름 | |
US7084082B1 (en) | Collagen material and its production process | |
CN106029361B (zh) | 替代组织的多层基体及其用途 | |
KR20040025926A (ko) | 유착 방지재 | |
JP4968976B2 (ja) | コラーゲン材及びその製法 | |
CA2387099C (en) | Artificial dura mater | |
JP3559885B2 (ja) | 人工硬膜 | |
JP3671273B2 (ja) | 人工硬膜 | |
JP3743566B2 (ja) | 人工硬膜 | |
JP2010029684A (ja) | コラーゲン材及びその製法 | |
WO2021045177A1 (ja) | 医療用補綴材 | |
JP2009131358A (ja) | 人工硬膜 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 98809919.5 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AU BA BB BG BR CA CN CU CZ EE GD GE HR HU ID IL IS JP KR LC LK LR LT LV MG MK MN MX NO NZ PL RO SG SI SK SL TR TT UA US UZ VN YU |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2305410 Country of ref document: CA Ref document number: 2305410 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09529073 Country of ref document: US Ref document number: 1020007003695 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998945613 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1998945613 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020007003695 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1020007003695 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1998945613 Country of ref document: EP |